Economic burden of tyrosine kinase inhibitor (TKI) treatment failure in patients with chronic myeloid leukemia (CML).

被引：0
|
作者：
Chen, Yaozhu J.
Huang, Hui
Divino, Victoria
Pokras, Shibani
Hallinan, Shawn
Munakata, Julie
Taylor, Catherine
McGarry, Lisa
Ng, Daniel
Nieset, Christopher
Knopf, Kevin B.
机构：
[1] IMS Hlth, Alexandria, VA USA
[2] ARIAD Pharmaceut Inc, Cambridge, MA USA
[3] IMS Hlth, San Francisco, CA USA
[4] ARIAD, Cambridge, MA USA
[5] Calif Pacific Med Ctr, San Francisco, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.7091
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7091
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Symptoms Following Discontinuation of Tyrosine Kinase Inhibitor (TKI) Therapy After Achieving an Adequate Response in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
    Ritchie, Ellen K.
    Sadek, Islam
    Pivneva, Irina
    Guerin, Annie
    Latremouille-Viau, Dominick
    Ndife, Briana
    Joseph, George J.
    Atallah, Ehab L.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S221 - S222
  • [42] Estimated Glomerular Filtration Rate Changes In Patients (Pts) With Chronic Myeloid Leukemia (CML) Treated With Tyrosine Kinase Inhibitors (TKI)
    Yilmaz, Musa
    Kantarjian, Hagop M.
    Quintas-Cardama, Alfonso
    O'Brien, Susan
    Burger, Jan A.
    Ferrajoli, Alessandra
    Borthakur, Gautam
    Ravandi, Farhad
    Pierce, Sherry
    Jabbour, Elias
    Cortes, Jorge E.
    BLOOD, 2013, 122 (21)
  • [43] Clarithromycin potentiates tyrosine kinase inhibitor treatment in patients with resistant chronic myeloid leukemia
    Carella, Angelo Michele
    Beltrami, Germana
    Pica, Gianmatteo
    Carella, Andrea
    Catania, Gioacchino
    LEUKEMIA & LYMPHOMA, 2012, 53 (07) : 1409 - 1411
  • [44] Frontline Tyrosine Kinase Inhibitors (TKI) As Initial Therapy for Patients with Chronic Myeloid Leukemia in Accelerated Phase (CML-AP)
    Ohanian, Maro
    Kantarjian, Hagop M.
    Quintas-Cardama, Alfonso
    O'Brien, Susan
    Verstovsek, Srdan
    Borthakur, Gautam
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Burton, Elizabeth M.
    Trinh, Long Xuan
    Ferrajoli, Alessandra
    Jabbour, Elias
    Kadia, Tapan
    Cortes, Jorge E.
    BLOOD, 2011, 118 (21) : 1614 - 1615
  • [45] Psychological Factors Affecting the Willingness to Accept a Possible Tyrosine Kinase Inhibitor (TKI) Discontinuation in Chronic Myeloid Leukaemia (CML) Patients
    Cutica, Ilaria
    Riva, Silvia
    Orlandi, Ester Maria
    Iurlo, Alessandra
    Vener, Claudia
    Elena, Chiara
    Bucelli, Cristina
    Cattaneo, Daniele
    Tomezzoli, Elisa
    Pravettoni, Gabriella
    PATIENT PREFERENCE AND ADHERENCE, 2022, 16 : 2963 - 2975
  • [46] The Economic Burden of Pleural Effusions (PE) In Patients with Chronic Myeloid Leukemia (CML)
    Wu, Eric Qiong
    Guerin, Annie
    Bollu, Vamsi
    Williams, Denise
    Guo, Amy
    Barido, Diego Ponce de Leon
    Yu, Andrew Peng
    Quintas-Cardama, Alfonso
    BLOOD, 2010, 116 (21) : 1571 - 1572
  • [47] Incidence, Interpretation and Management of Liver Function Abnormalities in Patients with Chronic Myeloid Leukemia (CML) Treated with Tyrosine Kinase Inhibitors (TKI)
    Robertson, Harry F.
    Orovboni, Victoria
    Bahk, Jeeyune
    Szydlo, Richard
    Fernando, Fiona R.
    Khan, Afzal
    Toma, Sarmad
    Hayden, Chloe
    Claudiani, Simone
    Innes, Andrew J.
    Milojkovic, Dragana
    Apperley, Jane F.
    BLOOD, 2023, 142
  • [48] Tyrosine Kinase Inhibitor Treatment for Newly Diagnosed Chronic Myeloid Leukemia
    Radich, Jerald P.
    Mauro, Michael J.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (04) : 577 - +
  • [49] Pregnancies in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitor
    Zhou, Li
    You, Jian-Hua
    Wu, Wen
    Li, Jun-Min
    Shen, Zhi-Xiang
    Wang, Ai-Hua
    LEUKEMIA RESEARCH, 2013, 37 (10) : 1216 - 1221
  • [50] High Density SNP Array Analysis of Tyrosine Kinase Inhibitor (TKI) Resistant Chronic Myeloid Leukemia (CML) Shows Secondary Genomic Alterations
    Nowak, Daniel
    Kawamata, Norihiko
    Akagi, Tadayuki
    Okamoto, Ryoko
    Thoennissen, Nils
    Hofmann, Wolf-Karsten
    Kato, Motohiro
    Haferlach, Torsten
    Ogawa, Seishi
    Koeffler, H. Phillip
    BLOOD, 2008, 112 (11) : 1091 - 1092
12345